Stay updated on Autologous Lymphocytes in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Autologous Lymphocytes in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous Lymphocytes in CLL/SLL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The change on the webpage now reflects updated eligibility criteria for researchers looking for patients with CLL or SLL, specifying different cohorts based on disease progression and treatment history, including criteria related to BTK resistance mutations and prior therapies.
    Difference
    33%
    Check dated 2024-05-22T08:16:01.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    12 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated completion date for the medical study related to autologous peripheral blood lymphocytes in the treatment of patients with CLL or SLL.
    Difference
    0.1%
    Check dated 2024-05-14T02:01:14.000Z thumbnail image
  7. Check
    14 days ago
    Change Detected
    Summary
    The webpage now shows that the study at University of Utah, Huntsm has changed from 'Withdrawn' to 'Active, not recruiting' with updated estimated completion dates.
    Difference
    5%
    Check dated 2024-05-11T19:27:31.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T23:12:41.000Z thumbnail image

Stay in the know with updates to Autologous Lymphocytes in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous Lymphocytes in CLL/SLL Clinical Trial page.